Institutional investors purchased a net $51.5 million shares of ABBV during the quarter ended March 2015 and now own 76.41% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
AXA INVESTMENT MANAGERS UK LTD. Bought 721.6 Thousand shares of AbbVie
BI ASSET MANAGEMENT FONDSMÆGLERS... Bought 441.7 Thousand shares of AbbVie
HANDELSBANKEN FONDER AB Bought 176.6 Thousand shares of AbbVie